How Enhancing Immunity to Low‐Risk HPV Could Cure Recurrent Respiratory Papillomatosis

Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis

(2020) Rebecca C. Hoesli et al.   JAMA Otolaryngology-Head & Neck Surgery

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

(2020) Aggarwal et al.   Vaccines

Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis

(2020) Husein Husein-ElAhmed   INTERNATIONAL JOURNAL OF STD & AIDS

The subjective well-being effect of public goods provided by village collectives: Evidence from China

(2020) Lili Li et al.   PLoS One

In RRP, serologic response to HPV is frequently absent and slow to develop

(2020) Farrel J. Buchinsky et al.   PLoS One

Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP)

(2020) Mohd Israr et al.   Frontiers in Immunology

MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis

(2019) Olga Rodriguez Cabo Beltran et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Experimental research on the therapeutic effect of MMR vaccine to juvenile-onset recurrent respiratory papillomatosis

(2019) Yu Wang et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement.

(2019) Sara I. Pai et al.   JOURNAL OF CLINICAL ONCOLOGY

Multi‐Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis

(2019) Hiroumi Matsuzaki et al.   LARYNGOSCOPE

Update on Recurrent Respiratory Papillomatosis

(2019) Craig S. Derkay et al.   OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA

Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

(2019) Clint T. Allen et al.   Journal for ImmunoTherapy of Cancer

Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis

(2019) Scott B. Drutman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A retrospective case-control analysis of the efficacy of Gardasil® vaccination in 28 patients with recurrent respiratory papillomatosis of the larynx

(2018) T.D. Milner et al.   CLINICAL OTOLARYNGOLOGY

Development of Human-Derived Cell Culture Lines for Recurrent Respiratory Papillomatosis

(2018) James Attra et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis

(2018) Paul Stefan Mauz et al.   BMC INFECTIOUS DISEASES

Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis

(2018) Chu-qin Zhang et al.   JOURNAL OF VOICE

Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis

(2018) Tine Rosenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Safe use of systemic bevacizumab for respiratory recurrent papillomatosis in two children

(2018) Claudio Carnevale et al.   LARYNGOSCOPE

PD-L1 expression and CD8+ infiltration shows heterogeneity in juvenile recurrent respiratory papillomatosis

(2017) Tingyu Liu et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis

(2017) Julie Ahn et al.   LARYNGOSCOPE

Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey

(2017) Simon R. Best et al.   LARYNGOSCOPE

Manipulation of the innate immune response by human papillomaviruses

(2017) Shiyuan Hong et al.   VIRUS RESEARCH

The low-risk papillomaviruses

(2017) Nagayasu Egawa et al.   VIRUS RESEARCH

Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma

(2017) Tara J. Nulton et al.   Oncotarget

Local Injection of Bevacizumab (Avastin) and Angiolytic KTP Laser Treatment of Recurrent Respiratory Papillomatosis of the Vocal Folds: A Prospective Study

(2017) Steven M. Zeitels et al.   ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY

Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study

(2016) S. J. Pamnani et al.   CANCER RESEARCH

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

(2016) M. I. E. van Poelgeest et al.   CLINICAL CANCER RESEARCH

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis

(2016) Robin E. A. Tjon Pian Gi et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

(2015) Jamie Rossjohn et al.   Annual Review of Immunology

The Use of the Quadrivalent Human Papillomavirus Vaccine (Gardasil) as Adjuvant Therapy in the Treatment of Recurrent Respiratory Papilloma

(2015) David L. Young et al.   JOURNAL OF VOICE

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia

(2015) Nagayasu Egawa et al.   Viruses-Basel

Xenograft Model for Therapeutic Drug Testing in Recurrent Respiratory Papillomatosis

(2014) Julie Ahn et al.   ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY

Unknown

(2014) James DeVoti et al.   MOLECULAR MEDICINE

Recurrent Respiratory Papillomatosis: HPV Genotypes and Risk of High-Grade Laryngeal Neoplasia

(2014) Turid Omland et al.   PLoS One

Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis

(2014) MICHAEL MOHR et al.   Oncology Letters

Targeting human papillomavirus genome replication for antiviral drug discovery

(2013) Jacques Archambault et al.   ANTIVIRAL THERAPY

Unknown

(2013) David Rosenthal et al.   MOLECULAR MEDICINE

Papillomavirus E6 oncoproteins

(2013) Scott B. Vande Pol et al.   VIROLOGY

Immune Suppression in Premalignant Respiratory Papillomas: Enriched Functional CD4+Foxp3+ Regulatory T Cells and PD-1/PD-L1/L2 Expression

(2012) L. J. Hatam et al.   CLINICAL CANCER RESEARCH

Age-Specific Human Papillomavirus Antibody and Deoxyribonucleic Acid Prevalence: A Global Review

(2012) Sarah M. Tiggelaar et al.   JOURNAL OF ADOLESCENT HEALTH

Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis

(2012) Maura L. Gillison et al.   VACCINE

The Biology and Life-Cycle of Human Papillomaviruses

(2012) John Doorbar et al.   VACCINE

Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis

(2011) Małgorzata Wierzbicka et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Papillomavirus-Specific CD4+ T Cells Exhibit Reduced STAT-5 Signaling and Altered Cytokine Profiles in Patients with Recurrent Respiratory Papillomatosis

(2011) E. A. James et al.   JOURNAL OF IMMUNOLOGY

Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients

(2010) S. Wu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy

(2009) Atikun Limsukon et al.   CHEST

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis

(2009) Vincent R. Bonagura et al.   HUMAN IMMUNOLOGY

Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children

(2009) Ireneusz Bielecki et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

(2009) R. C. Kines et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression

(2009) Dohun Pyeon et al.   PLoS Pathogens